Cargando…
Irisin is an Effector Molecule in Exercise Rehabilitation Following Myocardial Infarction (Review)
Background: Regular exercise is an effective non-pharmacological therapy for treatment and prevention of cardiovascular disease (CVD). The therapeutic benefits of exercise are mediated partly through improved vascular and increase in metabolic health. Release of exercise-responsive myokines, includi...
Autores principales: | Qin, Shuguang, Tian, Zhenjun, Boidin, Maxime, Buckley, Benjamin J. R., Thijssen, Dick H. J., Lip, Gregory Y. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276959/ https://www.ncbi.nlm.nih.gov/pubmed/35845994 http://dx.doi.org/10.3389/fphys.2022.935772 |
Ejemplares similares
-
Atrial Fibrillation Specific Exercise Rehabilitation: Are We There Yet?
por: Buckley, Benjamin J. R., et al.
Publicado: (2022) -
FNDC5/Irisin Inhibits the Inflammatory Response and Mediates the Aerobic Exercise-Induced Improvement of Liver Injury after Myocardial Infarction
por: Wang, Tao, et al.
Publicado: (2023) -
Dynamic changes of monocytes subsets predict major adverse cardiovascular events and left ventricular function after STEMI
por: Boidin, Maxime, et al.
Publicado: (2023) -
Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation
por: Buckley, Benjamin J. R., et al.
Publicado: (2021) -
Exercise‐Based Cardiac Rehabilitation and All‐Cause Mortality Among Patients With Atrial Fibrillation
por: Buckley, Benjamin J. R., et al.
Publicado: (2021)